NEW YORK (TheStreet) -- Jefferies reduced its price target on TeamHealth Holdings (TMH)  to $65 from $80, but maintained its "buy" rating and positive view on the stock on Thursday morning.

The Knoxville, TN-based company is a provider of outsourced healthcare professional staffing and administrative services to hospitals and other healthcare providers in the U.S.

"We remain a positive on TMH and believe the name has been de-risked significantly as Street expectations for 2016 and the stock's valuation have reset meaningfully in the last few weeks," the firm said in an analyst note.

Jefferies continues to believe the company's acquisition of IPC Healthcare will yield meaningful earnings upside.

TeamHealth will figure prominently in the continuing consolidation of the physician services space, the firm added.

Shares of TeamHealth are gaining by 1.61% to $42.23 in after-hours trading on Thursday.

Separately, TheStreet Ratings Team has a "buy" rating with a score of B- on the stock. 

This is driven by a number of strengths, which the team believes should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks it covers.

The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and notable return on equity.

TheStreet Ratings believes strengths outweigh the fact that the company has had lackluster performance in the stock itself.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: TMH